Dublin, Ireland: ERS Genomics Limited (‘ERS’) is pleased to announce a license agreement with Central Institute for Experimental Animals (“CIEA”) in Japan. This is a non-exclusive licensing agreement granting CIEA access to the ERS CRISPR/Cas9 patent portfolio. ERS, co-founded by Dr. Emmanuelle Charpentier, 2020 Nobel Prize winner for gene-editing, provides access to the foundational CRISPR/Cas9 […]

Advanced Cybersecurity with State-of-the-Art Encryption Features and Biomanufacturing Compliance Enablement SEATTLE — NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced the commercial unveiling of the nCounter® Pro Analysis System, the next generation of the nCounter instrument platform. The new system requires minimal bioinformatics support and […]

Version includes a powerful capability for genomic scar analysis for assessments of homologous recombination deficiency (HRD) that provides an efficient, consistent approach for analysis of tumor biomarkers used in pharmacogenomics and other cancer research SAN DIEGO — Bionano Genomics, Inc. (BNGO), pioneer of optical genome mapping (OGM) solutions on the Saphyr® system and provider of NxClinical™ […]

Codetta’s digital spatial PCR platform will improve translational research and the development of new multi-omic diagnostics MORRISVILLE, N.C. — Codetta Biosciences, the pioneer in digital spatial polymerase chain reaction (dsPCR) and digital spatial immuno polymerase chain reaction (dsiPCR), announced today that it has raised $15 million in Series A financing, led by Anzu Partners with additional funding […]

CAMBRIDGE, Mass. & NEW YORK — Ultivue, an industry leader in multiplexing tools for tissue biomarker analysis, and Paige, the global leader in AI-based diagnostic software in pathology, today announced a partnership to collaborate on the co-development and co-marketing of AI-powered spatial immunophenotype capabilities to pharmaceutical and research customers. Collaborative efforts will initially focus on the […]

New Sample Preparation Harmonization Designed to Enable miRNA and mRNA Profiling Without the Need for Additional Sample TUCSON, Ariz. — HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, announced that it has improved the sample preparation protocol for its miRNA Whole Transcriptome Assay […]

Companies will showcase combined solution at American Association for Cancer Research (AACR) Annual Meeting 2022 BOSTON — Stilla Technologies, the multiplex digital PCR company, and Promega Corporation today announced a co-marketing agreement that combines sample preparation with the latest Maxwell® systems and digital PCR on the six-color naica® system. With this partnership, the companies will offer an optimized workflow for a wide […]

MANASSAS, Virginia – Ceres Nanosciences (Ceres), a privately held company that makes innovative products to improve life science research and diagnostic testing, is announcing the establishment of six new wastewater-based epidemiology centers of excellence. The new centers add to the nine existing centers of excellence previously announced in November 2021 and to the wastewater testing program in […]

An increasing number of ANAB or AL2A certified forensic laboratories in the U.S. are now using STRmix™ – sophisticated forensic software capable of resolving mixed DNA profiles previously regarded as too complex or degraded to interpret – in casework, according to statistics recently compiled by STRmix™. The new data indicate that 80% of certified U.S. […]

Biospecimen Leader to Combine Gentest with Recent IVAL Acquisition to Create Leading In Vitro Drug Metabolism Services Offering HUNTSVILLE, Ala. — Discovery Life Sciences™ (Discovery), the biospecimen and biomarker specialists™, announced today that it has acquired the Gentest® business unit, part of Corning Incorporated’s Life Sciences business. The acquisition of Gentest complements Discovery’s recent acquisition of In Vitro ADMET […]